Published in Anesth Analg on May 19, 2011
Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways. Regul Pept (2013) 0.98
Peripheral calcitonin gene-related peptide receptor activation and mechanical sensitization of the joint in rat models of osteoarthritis pain. Arthritis Rheumatol (2014) 0.98
Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome. Mol Pain (2012) 0.96
miR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression. Anesthesiology (2012) 0.96
Common mechanisms of pain and depression: are antidepressants also analgesics? Front Behav Neurosci (2014) 0.92
Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome. Pain (2013) 0.86
Acute and chronic phases of complex regional pain syndrome in mice are accompanied by distinct transcriptional changes in the spinal cord. Mol Pain (2013) 0.83
Calcitonin gene-related peptide receptor antagonists: beyond migraine pain--a possible analgesic strategy for osteoarthritis? Curr Pain Headache Rep (2013) 0.81
Effects of a skin neuropeptide (substance p) on cutaneous microflora. PLoS One (2013) 0.81
Skin matters! The role of keratinocytes in nociception: a rational argument for the development of topical analgesics. J Pain Res (2016) 0.77
Mechanosensory and ATP Release Deficits following Keratin14-Cre-Mediated TRPA1 Deletion Despite Absence of TRPA1 in Murine Keratinocytes. PLoS One (2016) 0.76
The inflammasome as a target for pain therapy. Br J Anaesth (2016) 0.76
Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation. Trends Immunol (2016) 0.75
The inflammasome in fibromyalgia and CRPS: a microglial hypothesis? Nat Rev Rheumatol (2015) 0.75
Calcitonin gene-related peptide and pain: a systematic review. J Headache Pain (2017) 0.75
Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05
The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol (2009) 7.80
Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell (2007) 4.33
NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol (2003) 4.08
NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med (2007) 3.99
Inflammasomes: guardians of cytosolic sanctity. Immunol Rev (2009) 3.58
Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem (2006) 3.20
Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci (2007) 3.01
The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe (2008) 2.71
Nociceptors are interleukin-1beta sensors. J Neurosci (2008) 2.26
Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol (2008) 2.17
Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin. Cell Death Differ (2003) 2.02
Genomic analysis of the immune gene repertoire of amphioxus reveals extraordinary innate complexity and diversity. Genome Res (2008) 1.92
Role of interleukin-1beta during pain and inflammation. Brain Res Rev (2008) 1.62
Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones. Biochemistry (1994) 1.57
CA-074Me protection against anthrax lethal toxin. Infect Immun (2009) 1.55
Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm (2002) 1.50
Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett (2008) 1.50
Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin J Pain (2006) 1.42
Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett (1998) 1.35
Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol (2003) 1.28
Arthritis and pain. Neurogenic origin of joint pain. Arthritis Res Ther (2006) 1.21
The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome. Pain (2009) 1.17
Blockade of the complement C5a receptor reduces incisional allodynia, edema, and cytokine expression. Anesthesiology (2006) 1.16
The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain (2009) 1.15
Heme oxygenase type 2 modulates behavioral and molecular changes during chronic exposure to morphine. Neuroscience (2003) 1.08
Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain (2009) 1.07
Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I. Pain (2009) 1.05
Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides (2006) 1.04
Inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by a lipophilic inactivator of cysteine endopeptidases. Biochem J (1992) 0.99
Interleukin-1 signaling is required for induction and maintenance of postoperative incisional pain: genetic and pharmacological studies in mice. Brain Behav Immun (2008) 0.98
Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia. Glia (2010) 0.94
A partial catalog of proteins secreted by epidermal keratinocytes in culture. J Invest Dermatol (1999) 0.92
Interleukin-1alpha regulates substance P expression and release in adult sensory neurons. Exp Neurol (2009) 0.92
The growth and differentiation of cultured newborn rat keratinocytes. J Invest Dermatol (1983) 0.91
Calcitonin gene-related peptide regulates the expression of vascular endothelial growth factor in human HaCaT keratinocytes by activation of ERK1/2 MAPK. Regul Pept (2006) 0.89
Systemic inflammatory mediators in post-traumatic complex regional pain syndrome (CRPS I) - longitudinal investigations and differences to control groups. Eur J Med Res (2009) 0.89
Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome. Neurosci Lett (2004) 0.88
Caspase-1 modulates incisional sensitization and inflammation. Anesthesiology (2010) 0.88
Formalin-induced spinal cord calcium/calmodulin-dependent protein kinase II alpha expression is modulated by heme oxygenase in mice. Neurosci Lett (2004) 0.87
Evidence implicating matrix metalloproteinases in the mechanism underlying accumulation of IL-1beta and neuronal apoptosis in the neocortex of HIV/gp120-exposed rats. Int Rev Neurobiol (2007) 0.86
Profilaggrin requires both linker and filaggrin peptide sequences to form granules: implications for profilaggrin processing in vivo. J Invest Dermatol (1999) 0.83
The time course of inflammatory cytokine secretion in a rat model of postoperative pain does not coincide with the onset of mechanical hyperalgesia. Can J Physiol Pharmacol (2007) 0.82
Antisense profilaggrin RNA delays and decreases profilaggrin expression and alters in vitro differentiation of rat epidermal keratinocytes. J Invest Dermatol (1993) 0.82
Expression of substance P receptors in normal and psoriatic skin. Pathobiology (1999) 0.80
Experimental forearm immobilization in humans reduces capsaicin-induced pain and flare. Brain Res (2009) 0.79
Human skin keratinocytes and fibroblasts express adrenomedullin and its receptors, and adrenomedullin enhances their growth in vitro by stimulating proliferation and inhibiting apoptosis. Int J Mol Med (2003) 0.78
HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature (2002) 9.62
Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med (2008) 4.83
Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology (2006) 3.81
Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet (2013) 3.77
The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers. Cancer Res (2010) 3.16
Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell (2003) 3.03
Aversive and reinforcing opioid effects: a pharmacogenomic twin study. Anesthesiology (2012) 2.85
Mutagenic stabilization and/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein. J Virol (2002) 2.81
Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120. Structure (2008) 2.74
Pain sensitivity and opioid analgesia: a pharmacogenomic twin study. Pain (2012) 2.44
Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins. Proc Natl Acad Sci U S A (2004) 2.44
Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer. Nat Struct Mol Biol (2012) 2.36
Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state. PLoS Pathog (2009) 2.34
Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. Virology (2003) 2.25
Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions. Mol Cell (2010) 2.22
Structural basis of J cochaperone binding and regulation of Hsp70. Mol Cell (2007) 2.14
Hand, foot, and mouth disease in China: patterns of spread and transmissibility. Epidemiology (2011) 2.13
Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc (2006) 2.10
Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer. Proc Natl Acad Sci U S A (2013) 2.05
A genetic analysis of opioid-induced hyperalgesia in mice. Anesthesiology (2006) 1.97
Structure of the Hsp110:Hsc70 nucleotide exchange machine. Mol Cell (2008) 1.96
Spatial analysis of malaria in Anhui province, China. Malar J (2008) 1.92
Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains. Virology (2003) 1.90
Type-2 cells as link between glial and neuronal lineage in adult hippocampal neurogenesis. Glia (2006) 1.90
Functional imaging of colonic mucosa with a fibered confocal microscope for real-time in vivo pathology. Clin Gastroenterol Hepatol (2007) 1.85
Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurol (2011) 1.83
Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells. Cancer Res (2010) 1.78
Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer. Breast Cancer Res Treat (2012) 1.71
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor. J Med Chem (2008) 1.66
Analysis of αSMA-labeled progenitor cell commitment identifies notch signaling as an important pathway in fracture healing. J Bone Miner Res (2014) 1.66
Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem (2005) 1.65
Oil and tocopherol content and composition of pumpkin seed oil in 12 cultivars. J Agric Food Chem (2007) 1.65
Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology (2012) 1.64
High-affinity peptide against MT1-MMP for in vivo tumor imaging. J Control Release (2011) 1.59
Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav Brain Res (2007) 1.58
Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. J Pain (2003) 1.58
No evidence for the development of acute tolerance to analgesic, respiratory depressant and sedative opioid effects in humans. Pain (2009) 1.58
Brain neuroplastic changes accompany anxiety and memory deficits in a model of complex regional pain syndrome. Anesthesiology (2014) 1.56
Peripheral mechanisms of pain and analgesia. Brain Res Rev (2008) 1.55
Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology (2006) 1.54
Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1. J Virol (2004) 1.51
Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat (2007) 1.49
Contribution of intrinsic reactivity of the HIV-1 envelope glycoproteins to CD4-independent infection and global inhibitor sensitivity. PLoS Pathog (2011) 1.47
In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells (2012) 1.44
Improving the performance of outbreak detection algorithms by classifying the levels of disease incidence. PLoS One (2013) 1.36
Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med (2005) 1.34
Osterix-cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma. PLoS One (2013) 1.34
Diversity and abundance of oil-degrading bacteria and alkane hydroxylase (alkB) genes in the subtropical seawater of Xiamen Island. Microb Ecol (2010) 1.33
The role of interleukin-1 in wound biology. Part II: In vivo and human translational studies. Anesth Analg (2010) 1.32
Sex differences in reported pain across 11,000 patients captured in electronic medical records. J Pain (2012) 1.32
Morphine reduces local cytokine expression and neutrophil infiltration after incision. Mol Pain (2007) 1.31
Genetic control of floral zygomorphy in pea (Pisum sativum L.). Proc Natl Acad Sci U S A (2008) 1.27
Crystallization of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr (2006) 1.23
Transitions to and from the CD4-bound conformation are modulated by a single-residue change in the human immunodeficiency virus type 1 gp120 inner domain. J Virol (2009) 1.23
Emergence of a tetracycline-resistant Campylobacter jejuni clone associated with outbreaks of ovine abortion in the United States. J Clin Microbiol (2008) 1.23
Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity. J Bone Miner Res (2004) 1.22
Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors. Bioorg Med Chem Lett (2005) 1.20
Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody. J Virol (2005) 1.19
NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer. PLoS One (2011) 1.19
Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors. J Med Chem (2007) 1.17
Human exposure to live poultry and psychological and behavioral responses to influenza A(H7N9), China. Emerg Infect Dis (2014) 1.17
The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome. Pain (2009) 1.17
The role of interleukin-1 in wound biology. Part I: Murine in silico and in vitro experimental analysis. Anesth Analg (2010) 1.16
Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence. Pain (2006) 1.16
Blockade of the complement C5a receptor reduces incisional allodynia, edema, and cytokine expression. Anesthesiology (2006) 1.16
Detection of endogenous biomolecules in Barrett's esophagus by Fourier transform infrared spectroscopy. Proc Natl Acad Sci U S A (2007) 1.16
Aggressive angiomyxoma: an unusual presentation. Korean J Radiol (2011) 1.16
The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain (2009) 1.15
Glucocorticoid inhibition of vascular abnormalities in a tibia fracture rat model of complex regional pain syndrome type I. Pain (2006) 1.15
Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating Wnt/catenin signaling. Stem Cells (2011) 1.13
Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision. Mol Pain (2008) 1.13
Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome. Eur J Pain (2008) 1.13
Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain (2008) 1.12
A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain (2003) 1.11
From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenet Genomics (2009) 1.11
Long bone fracture repair in mice harboring GFP reporters for cells within the osteoblastic lineage. J Orthop Res (2010) 1.11
TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain (2007) 1.11
CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression. Sci Rep (2013) 1.11
Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators. Pain (2010) 1.09
Somatosensory and sensorimotor consequences associated with the heterozygous disruption of the autism candidate gene, Gabrb3. Behav Brain Res (2010) 1.09
Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma. Bioorg Med Chem Lett (2005) 1.08
Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain (2009) 1.07